From the Washington State Department of Health:
The Centers for Disease Control (CDC) recently updated adult vaccine recommendations related to hepatitis B vaccine, pneumococcal vaccine, and Shingrix.
Hepatitis B vaccine is now recommended for all adults aged 19-59 years regardless of risk factors, and anyone 60 years or older with risk factors. Hepatitis B vaccine may also be offered to all adults 60 years and older who wish to be vaccinated. PreHevbrio (VBI) is a new trivalent hepatitis B vaccine licensed in 2021 for use in adults age 18 or older as a 3-dose series given over 6 months.
Pneumococcal vaccines are recommended for all adults aged 65 years or older as well as adults aged 19-64 with certain underlying medical conditions or other risk factors. The new guidelines for PCV15, PCV20, and PPSV23 are listed in the table below as well as in the Adult Pneumococcal Vaccine Administration algorithm [link to algorithm on webpage].
The new Shingrix vaccine guidelines recommend that two doses be given for all adults aged 19 years or older who are immunocompromised or have other risk factors.
Below is a more detailed summary of the updated recommendations with additional resources.
|Vaccine||Summary of updated recommendations||Resources|
PCV15 or PCV20 vaccine is now recommended for adults 65 years or older or 19 years or older with immunocompromising conditions. When PCV15 is used, give PPSV23 at least 1 year later. Additional scenarios are described below.
Adults who qualify for pneumococcal vaccination but have not received any previous pneumococcal vaccines:
Adults who qualify for pneumococcal vaccination and have only received PPSV23:
Adults who qualify for pneumococcal vaccination and have only received PCV13: